Immune therapy for human papillomaviruses-related cancers

doi:10.5306/wjco.v5.i5.1002

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 5

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10650)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

577

WORD

522

HTML

6911

Figures (1-5)

247

Tables (1-1)

127

Sum=8384

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1127

Download

1139

Sum=2266

Dec 10, 2014 (publication date) through Jul 19, 2024

Times Cited of This Article

Times Cited (49)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Dec 10, 2014; 5(5): 1002-1019
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.1002

Full Size Figure Download Figure

Figure 5 Effects of vaccinia virus Ankara E2 on cervix and vulva. Colposcopy of papillomavirus-induced intraepithelial lesions from patients treated with the therapeutic recombinant vaccinia virus Ankara E2. Photographs of (A) cervix with a cervical intraepithelial neoplasia 3 lesion, and (B) vulva with a condyloma lesion, before and after treatment. MVA: Modified vaccinia virus Ankara.

Citation: Rosales R, Rosales C. Immune therapy for human papillomaviruses-related cancers. World J Clin Oncol 2014; 5(5): 1002-1019
URL: https://www.wjgnet.com/2218-4333/full/v5/i5/1002.htm
DOI: https://dx.doi.org/10.5306/wjco.v5.i5.1002